Shiga toxin-induced haemolytic uraemic syndrome and the role of antibiotics: a global overview
- 1 August 2019
- journal article
- review article
- Published by Elsevier BV in Journal of Infection
- Vol. 79 (2), 75-94
- https://doi.org/10.1016/j.jinf.2019.05.018
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreakBMC Microbiology, 2012
- Effects of Antibiotics on Shiga Toxin 2 Production and Bacteriophage Induction by Epidemic Escherichia coli O104:H4 StrainAntimicrobial Agents and Chemotherapy, 2012
- Virulence Inhibition by Zinc in Shiga-Toxigenic Escherichia coliInfection and Immunity, 2011
- Different Classes of Antibiotics Differentially Influence Shiga Toxin ProductionAntimicrobial Agents and Chemotherapy, 2010
- Shiga Toxin 2 Is Specifically Released from Bacterial Cells by Two Different MechanismsInfection and Immunity, 2009
- Gnotobiotic Piglet Infection Model for Evaluating the Safe Use of Antibiotics againstEscherichia coliO157:H7 InfectionThe Journal of Infectious Diseases, 2009
- Subtype-Specific Suppression of Shiga Toxin 2 Released from Escherichia coli upon Exposure to Protein Synthesis InhibitorsJournal of Clinical Microbiology, 2008
- Rifaximin Does Not Induce Toxin Production or Phage-Mediated Lysis of Shiga Toxin-Producing Escherichia coliAntimicrobial Agents and Chemotherapy, 2007
- Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritisThe Journal of Pediatrics, 1992
- Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: Clinical and epidemiologic observationsThe Journal of Pediatrics, 1990